Indivior Pharmaceuticals (INDV) Free Cash Flow (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Free Cash Flow of -$29.0 million for Q1 2026, down 141.43% year-over-year from $70.0 million in Q1 2025, and up 88.16% quarter-over-quarter from -$245.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Free Cash Flow (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Free Cash Flow history runs 3 years deep, the most recent figure standing at -$29.0 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 141.43% year-over-year to -$29.0 million; the TTM figure through Mar 2026 stood at -$192.0 million (down 265.52% YoY), while the FY2025 annual figure was -$93.0 million, down 1428.57% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$29.0 million, up from -$245.0 million in the prior quarter.
- The five-year high for Free Cash Flow was $141.0 million in Q2 2025, with the low at -$245.0 million in Q4 2025.
- The 3-year median for Free Cash Flow is -$29.0 million (2026), against an average of -$12.8 million.
- Peak annual rise in Free Cash Flow reached 279.49% in 2025, while the deepest fall reached 1080.0% in 2025.
- Indivior Pharmaceuticals' Free Cash Flow stood at -$33.0 million in 2024, then tumbled by 642.42% to -$245.0 million in 2025, then soared by 88.16% to -$29.0 million in 2026.
- Business Quant data shows INDV's Free Cash Flow at -$29.0 million in Q1 2026, -$245.0 million in Q4 2025, and -$59.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Indivior Pharmaceuticals | 4.51 Bn | 4.29 Bn | 294.00 Mn | 222.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 222.00 Mn |
| Jun 30, 2026 | 222.00 Mn |
| Mar 31, 2026 | -29.00 Mn |
| Mar 31, 2026 | -29.00 Mn |
| Dec 31, 2025 | -245.00 Mn |
| Dec 31, 2025 | -245.00 Mn |
| Sep 30, 2025 | -59.00 Mn |
| Sep 30, 2025 | -59.00 Mn |
| Jun 30, 2025 | 141.00 Mn |
| Jun 30, 2025 | 141.00 Mn |
| Mar 31, 2025 | 70.00 Mn |
| Mar 31, 2025 | 70.00 Mn |
| Dec 31, 2024 | -33.00 Mn |
| Dec 31, 2024 | -33.00 Mn |
| Sep 30, 2024 | -5.00 Mn |
| Sep 30, 2024 | -5.00 Mn |
| Jun 30, 2024 | 84.00 Mn |
| Jun 30, 2024 | 84.00 Mn |
| Mar 31, 2024 | -39.00 Mn |
| Mar 31, 2024 | -39.00 Mn |